Related Experiment Video
Updated: May 9, 2026

Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models
Published on: September 27, 2024
Buprenorphine therapy: an increasing challenge in oral and maxillofacial surgery
Michael Wasson1, O Ross Beirne
1Department of Oral and Maxillofacial Surgery, University of Washington, Seattle, WA 98195-7134, USA.
Abstract:
Suboxone is a 4:1 mixture of buprenorphine and naloxone and Subutex is buprenorphine alone. The high affinity μ-receptor binding of buprenorphine (Suboxone and Subutex) renders other opioids ineffective. Inadequate procedural sedation, inadequate analgesia, and significant drug interactions complicate the treatment of patients taking Suboxone or Subutex. Careful planning and an understanding of buprenorphine pharmacology can minimize potential perioperative complications in patients taking Suboxone or Subutex.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Oral Drug Delivery Systems: Introduction
Analgesia and Pain Management
Oral Drug Delivery Systems: Continuous-Release Systems
Drug Delivery: Enteral Route
Drugs in...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease

